The following represents disclosure information provided by authors of this abstract. The Gastrointestinal Cancers Symposium Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Impact of mismatch repair (MMR) testing on colorectal cancer (CRC) oncology clinical practice.
Madeleine Hewish
No relevant relationships to disclose
Gordon Stamp
No relevant relationships to disclose
Loretto Puckey
No relevant relationships to disclose
Susan Shanley
No relevant relationships to disclose
Clare Costello
No relevant relationships to disclose
Janine Webb
No relevant relationships to disclose
Sanna Hulkki Wilson
No relevant relationships to disclose
David Gonzalez de Castro
No relevant relationships to disclose
Yolanda Barbachano
No relevant relationships to disclose
Claire Saffery
No relevant relationships to disclose
Charles Swanton
No relevant relationships to disclose
Christopher J. Lord
Other Remuneration - AstraZeneca
Jorge S. Reis-Filho
No relevant relationships to disclose
Alan Ashworth
Employment or Leadership Position - RMH Foundation Trust
Consultant or Advisory Role - Champalimaud Foundation (U); GlaxoSmithKline; Queen's University Belfast (U)
Honoraria - Clovis Oncology; Merck Serono; Roche
Research Funding - Kudos pharmaceuticals
Other Remuneration - AstraZeneca
Ian Chau
No relevant relationships to disclose
David Cunningham
Consultant or Advisory Role - Amgen (U); Roche/Genentech (U)
Research Funding - Amgen; Merck Serono; Merck Sharp & Dohme; Roche; Sanofi